Telix Pharmaceuticals Limited (TLX)
NASDAQ: TLX · Real-Time Price · USD
13.31
+0.26 (1.99%)
At close: Aug 4, 2025, 4:00 PM
13.32
+0.01 (0.08%)
After-hours: Aug 4, 2025, 4:10 PM EDT

Despegar.com Stock Forecast

Stock Price Forecast

The 3 analysts that cover Despegar.com stock have a consensus rating of "Strong Buy" and an average price target of $22.33, which forecasts a 67.77% increase in the stock price over the next year. The lowest target is $22 and the highest is $23.

Price Target: $22.33 (+67.77%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$22$22.33$22$23
Change+65.29%+67.77%+65.29%+72.80%
* Price targets were last updated on Jul 3, 2025.

Analyst Ratings

The average analyst rating for Despegar.com stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingMar '25Apr '25May '25Jun '25Jul '25
Strong Buy11112
Buy00011
Hold00000
Sell00000
Strong Sell00000
Total11123

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Initiates
$23
Strong BuyInitiates$23+72.80%Jul 3, 2025
Wedbush
Wedbush
Buy
Reiterates
$22
BuyReiterates$22+65.29%Jun 12, 2025
Wedbush
Wedbush
Buy
Initiates
$22
BuyInitiates$22+65.29%Jun 5, 2025
UBS
UBS
Strong Buy
Maintains
$21$22
Strong BuyMaintains$21$22+65.29%Jan 27, 2025
UBS
UBS
Strong Buy
Initiates
$21
Strong BuyInitiates$21+57.78%Nov 15, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
n/a
EPS Next Year
n/a
No financial forecasts available for this stock

Revenue Forecast

No data available

Revenue Growth

No data available

EPS Forecast

No data available

EPS Growth

No data available
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.